Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jingmen Shangqing Pill
- Development stage
- Unknown
- Lead developer
- Hubei Qijin Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Jingmen Shangqing Pill is a Traditional Chinese Medicine (TCM) formulation developed and manufactured by Hubei Qijin Pharmaceutical Co., Ltd. It is primarily indicated for the treatment of recurrent aphthous ulcers (RAU) and other conditions associated with upper burner heat in TCM theory, such as sore throat, gingivitis, and toothache. The formulation consists of a complex blend of herbal ingredients, including Schizonepeta, Saposhnikovia, Forsythia, and Rhubarb, which provide anti-inflammatory, analgesic, and heat-clearing properties. By modulating inflammatory mediators and promoting mucosal healing, it effectively reduces the pain and duration of oral ulcers. It is typically administered orally in pill form and is available as an over-the-counter medication in China.
- Brand names
- Jingmen Shangqing Pill
- Other names
- Jingmen Shangqing Wan荆门上清丸Jingzhi Shangqing Wan
02
Targets
TNFA (Tumor necrosis factor alpha (soluble))IL-6 (Interleukin 6)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)
Beyond the preview
Go deeper on Jingmen Shangqing Pill.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jingmen Shangqing Pill.